PBRER
Explore all topics, guides, and frameworks related to PBRER.
Articles in this section
12- How to Write a PBRER A PBRER is not a compilation of periodic safety data but a cumulative scientific assessment focused on what changed during the reporting interval and whether the product's benefit-risk balance remains favourable. This article explains the regulatory framework, planning method, section architecture, evidence integration and review process used to produce a coherent report. Read Article →
- Understanding the Structure of a PBRER Explains how the major PBRER sections relate to one another, why descriptive sections matter to later interpretation, and how authors can maintain one coherent scientific narrative across the report. Read Article →
- Writing the Executive Summary in a PBRER Explains what the PBRER executive summary should communicate, why it is usually drafted after the main scientific sections, how to select proportionate content and how to maintain consistency with risk, benefit-risk and conclusions sections. Read Article →
- Writing the Worldwide Marketing Authorisation Status Section in a PBRER Explains how the worldwide authorisation-status section establishes the product's regulatory footprint without becoming a country-by-country administrative history, and how safety-driven authorisation actions connect to later PBRER sections. Read Article →
- Writing the Overall Conclusion and Actions Section in a PBRER Explains how the final PBRER section should state what the cumulative evidence means, distinguish conclusions from proposed or completed actions, and remain consistent with the integrated benefit-risk evaluation and regulatory status. Read Article →
- Writing the Signal Evaluation Section in a PBRER Explains how the PBRER signal section reports scientifically important signal activity without duplicating the operational signal-management system, and how completed evaluations feed later risk and benefit-risk conclusions. Read Article →
- Writing the Changes to Reference Safety Information Section in a PBRER Explains how to identify the reference information used for the PBRER, describe clinically meaningful safety changes during the reporting interval, handle multiple versions and regional implementation differences, and connect those changes to later signal, risk and benefit-risk evaluation. Read Article →
- Writing the Data in Summary Tabulations Section in a PBRER Explains how summary tabulations organise interval and cumulative safety data, how authors verify the underlying dataset and counting methodology, and how to distinguish descriptive case counts from scientific conclusions about frequency, causality or risk. Read Article →
- Periodic Benefit-Risk Evaluation Reports (PBRER) Explains what PBRERs and EU PSURs are, why they exist, how ICH E2C(R2) and GVP Module VII fit together, how reporting schedules are determined and how the report supports periodic benefit-risk evaluation. Read Article →
- Writing the Actions Taken for Safety Reasons Section in a PBRER Explains how to identify, organise and write significant safety-related actions in a PBRER so the section provides regulatory context without duplicating later signal, risk or benefit-risk evaluations. Read Article →
- Writing the Evaluation of Risks and New Information Section in a PBRER Explains how the PBRER risk-evaluation section synthesises new and cumulative evidence, distinguishes identified risks, potential risks and missing information, and shows whether the scientific understanding of each safety concern has changed. Read Article →
- Writing the Integrated Benefit-Risk Evaluation Section in a PBRER Explains how to move from separate benefit and risk evaluations to an integrated judgement for authorised use, how to handle population-specific differences and uncertainty, and how to make the conclusion traceable to the evidence presented earlier in the report. Read Article →